Toggle navigation
Home
Search
Services
Blog
Contact
About
Develop Monoclonal Antibodies to Tumor Growth Factors
Ranken, Raymond
Biocircuits Corporation, Burlingame, CA, United States
Search 7 grants from Raymond Ranken
Search grants from Biocircuits Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Atomic basis for chloride channel and transporter gating and selectivity
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis
Characterization of cranial dermal bone-specific miRNAs
Human Cytochrome P450 4F Enzymes and Drug Interactions
Sex Steroids, Obesity and Lipids in Adolescent Females
Recently added grants:
Targeting ALK through Degradation and Allosteric Inhibitors
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
Metabolic Constraints on Cancer Cell Proliferation
Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057762-000
Application #
3613353
Study Section
Project Start
1985-09-23
Project End
Budget Start
1985-09-23
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Biocircuits Corporation
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Comments
Be the first to comment on Raymond Ranken's grant